NuvoAir
Series ARaised Since FeaturedBreathe easy, live better
Virtual-first specialty care platform for patients with complex heart and lung conditions.
About
NuvoAir Medical delivers next-generation cardiopulmonary care through a virtual-first specialty care model that combines Bluetooth-enabled spirometers, inhaler sensors, and a patient mobile app to remotely monitor lung function and deliver proactive, continuous care. Founded in 2015 by Lorenzo Consoli — inspired by his own childhood asthma and years at Novartis — the company has grown from a Swedish respiratory health startup into a U.S.-headquartered digital health platform serving patients across all 50 states and two continents. NuvoAir supports decentralized clinical trials across 20+ countries and has partnered with leading institutions including Harvard Boston Children's Hospital, Dartmouth-Hitchcock Medical Center, and pharmaceutical companies like Roche, Regeneron, and Novartis. Named to the 2025 Inc. 5000 list of America's fastest-growing private companies, NuvoAir has achieved a 75 Net Promoter Score (vs. healthcare average of 38), reduced urgent hospital visits by 39%, and maintained 95% platform retention.
DailyDropout Take
NuvoAir caught our attention as a founder-driven digital health company tackling one of medicine's most underserved areas — chronic respiratory disease. With Lorenzo Consoli's personal connection to asthma and deep Novartis experience, combined with a platform that bridges clinical trials and value-based care delivery, NuvoAir was positioned to become the digital backbone of pulmonary medicine.
Discovery signal: Strong founder-market fit (childhood asthma + Novartis background), Novartis as strategic investor, early traction in decentralized clinical trials across 20+ countries
What Makes Them Unique
NuvoAir uniquely combines remote spirometry, inhaler sensing, and a virtual care platform into a single integrated system — enabling both value-based specialty care delivery and decentralized clinical trials across 20+ countries, all from one platform.
75 (vs. 38 healthcare avg)
Net Promoter Score
39%
Hospital Visit Reduction
95%
Platform Retention
30+ across 20+ countries
Clinical Trials Supported
Target Markets
Founders
Lorenzo Consoli
Founder
Inspired by his childhood asthma, Lorenzo joined Novartis Respiratory Franchise in 2012 before founding NuvoAir in 2015 to transform respiratory care through digital health technology.
Key People
Previously: 20+ years in healthcare sales strategy
Previously: Practicing internal medicine specialist, 20+ years experience
Funding History
Lead: Industrifonden
Lead: AlbionVC
Lead: Hikma Ventures
Investors
Firms
Accelerators
Press & News
Inspired by founder's childhood asthma, NuvoAir raises $12M to tackle respiratory illnesses
NuvoAir raises $3M to help patients monitor respiratory diseases with AI
NuvoAir Series A Funding Reaches $25M
NuvoAir Medical Named to 2025 Inc. 5000